All mRNA vaccines articles
-
News
Repeated COVID vaccines enhance mucosal immunity against the virus
New work has found that repeated Covid-19 vaccinations lead to the presence of mucosal antibodies, for example, inside the nose.
-
News
New initiative launched to advance mRNA vaccine development against human avian influenza (H5N1)
A new project aiming to accelerate the development and accessibility of human avian influenza (H5N1) messenger RNA (mRNA) vaccine candidates for manufacturers in low- and middle-income countries has been launched
-
News
Researchers develop experimental mRNA avian flu vaccine
An experimental mRNA vaccine against avian influenza virus H5N1 is highly effective in preventing severe illness and death in preclinical models, according to a new study.
-
News
Scientists discover alternative base modification for mRNA therapeutics
Researchers have incorporated a newly discovered base, called base Z, into mRNA to create Z-mRNA that has improved translational capacity, decreased cytotoxicity and drastically reduced immunogenicity compared to unmodified mRNA.
-
News
Nobel Prize goes to researchers whose discoveries paved way for mRNA vaccines
The 2023 Nobel Prize in Physiology or Medicine has been awarded to Katalin Karikó and Drew Weissman for their discoveries concerning nucleoside base modifications that enabled the development of effective mRNA vaccines against COVID-19.
-
Opinion
New RSV vaccines on the way - so what do we do about vaccine hesitancy?
Not one, but two promising new vaccines are likely to be introduced to the UK, yet routine childhood vaccination rates have been decreasing for ‘old’ diseases like measles and polio - what’s going on?
-
News
Moderna is safest, most effective mRNA vaccine against COVID-19 for older adults
A study of older US adults found that the risk of negative effects of both mRNA vaccines is exceptionally low, but lowest with the Moderna vaccine.
-
News
Covid-19 jab shows no serious side effects in young children
A review of more than 245,000 doses of mRNA COVID-19 vaccines given to young children - most of them aged 4 and younger - found no indications of serious side effects.
-
News
Algorithm boosts Covid vaccine response 128-fold
Researchers have developed an AI algorithm that can rapidly design highly stable COVID-19 mRNA vaccine sequences that were previously unattainable, achieving a 128-fold increase in the vaccine’s antibody response.
-
News
mRNA ingredient produced by biocatalytic synthesis
The new and patented method for the production of the important mRNA vaccine component pseudouridine is more efficient, sustainable and cost-effective than the previously used chemical synthesis.